Medullary Thyroid Cancer (MTC)

Welcome

We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!

If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.

Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.

The latest in MTC news

News

Published: May 10th, 2026 at 12:45:53 AM

Red Sox Hall of Famer, Florida county commissioner Mike Greenwell dies - MSN

"Greenwell announced earlier this summer he had medullary thyroid cancer, NBC affiliate Gulf Coast News reported. Expand article logo Continue ..."

Published: May 9th, 2026 at 05:54:04 PM

A Look At Exelixis (EXEL) Valuation After Strong Q1 2026 Results And Zanzalintinib FDA Milestone

"... zanzalintinib alongside active share repurchases. See our latest analysis for Exelixis. The stock has cooled slightly after earnings, with a 1 day ..."

Published: May 9th, 2026 at 08:38:44 AM

Zepbound and erectile dysfunction: what the evidence and real-world experience show

"People with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Those with severe ..."

Published: May 8th, 2026 at 08:44:11 PM

Wegovy Canada: Cost, Availability, Side Effects, and How It Compares to Ozempic

"People with a personal or family history of medullary thyroid carcinoma should not use it. Wegovy Canada is a useful starting point if you want to ..."

Published: May 8th, 2026 at 08:01:07 AM

Lilly's Retevmo moves closer to Korea reimbursement coverage after key review approval

"... medullary thyroid cancer requiring systemic therapy. Another approved indication for the drug -- RET fusion-positive thyroid cancer -- was not ..."